Neuropathology Evaluation of Olney Lesions in Regulatory Drug Development Toxicology Studies
Saved in:
| Main Authors: | Deepa B. Rao, BVSc, M.S., Ph.D., David B. Hawver, Ph.D., David G. Hall, Ph.D., William H. Jordan, Ph.D. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924001041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detecting Demyelination by PET: The Lesion as Imaging Target
by: Pedro Brugarolas PhD, et al.
Published: (2018-07-01) -
Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice
by: Wendy E. Walker, PhD, et al.
Published: (2025-03-01) -
Extended segmentectomy for intersegmental lesions with intraoperative surgical margin assessment by radiofrequency identification markersCentral MessagePerspective
by: Yojiro Yutaka, MD, PhD, et al.
Published: (2024-12-01) -
Is a single lethal electric field threshold sufficient to characterize the lesion size in computational modeling of cardiac pulsed-field ablation?
by: Argyrios Petras, PhD, et al.
Published: (2025-05-01) -
Feasibility study of a novel wireless localization technique using radiofrequency identification markers for small and deeply located lung lesionsCentral MessagePerspective
by: Yojiro Yutaka, MD, PhD, et al.
Published: (2022-04-01)